The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients

  • Lee, Chang-Hoon (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Lee, Jinwoo (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Park, Young Sik (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Lee, Sang-Min (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Yim, Jae-Joon (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Kim, Young Whan (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Han, Sung Koo (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Yoo, Chul-Gyu (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine)
  • Received : 2014.04.29
  • Accepted : 2014.07.10
  • Published : 2015.09.01
⟨ Previous Next ⟩

Abstract

Background/Aims: In assigning patients with chronic obstructive pulmonary disease (COPD) to subgroups according to the updated guidelines of the Global Initiative for Chronic Obstructive Lung Disease, discrepancies have been noted between the COPD assessment test (CAT) criteria and modified Medical Research Council (mMRC) criteria. We investigated the determinants of symptom and risk groups and sought to identify a better CAT criterion. Methods: This retrospective study included COPD patients seen between June 20, 2012, and December 5, 2012. The CAT score that can accurately predict an mMRC grade ${\geq}2$ versus < 2 was evaluated by comparing the area under the receiver operating curve (AUROC) and by classification and regression tree (CART) analysis. Results: Among 428 COPD patients, the percentages of patients classified into subgroups A, B, C, and D were 24.5%, 47.2%, 4.2%, and 24.1% based on CAT criteria and 49.3%, 22.4%, 8.9%, and 19.4% based on mMRC criteria, respectively. More than 90% of the patients who met the mMRC criteria for the 'more symptoms group' also met the CAT criteria. AUROC and CART analyses suggested that a CAT score ${\geq}15$ predicted an mMRC grade ${\geq}2$ more accurately than the current CAT score criterion. During follow-up, patients with CAT scores of 10 to 14 did not have a different risk of exacerbation versus those with CAT scores < 10, but they did have a lower exacerbation risk compared to those with CAT scores of 15 to 19. Conclusions: A CAT score ${\geq}15$ is a better indicator for the 'more symptoms group' in the management of COPD patients.

Keywords

References

  1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated) [Internet]. GOLD, 2013 [cited 2015 Jul 28]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.
  2. The Korean Academy of Tuberculosis and Respiratory Diseases. Guidelines for chronic obstructive pulmonary disease 2012 [Internet]. Seoul (KR): KATRD, c2007 [cited 2015 Jul 28]. Available from: http://www.lungkorea.org.
  3. Zhou QT, Mei JJ, He B, et al. Chronic obstructive pulmonary disease assessment test score correlated with dyspnea score in a large sample of Chinese patients. Chin Med J (Engl) 2013;126:11-15.
  4. Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013;1:43-50. https://doi.org/10.1016/S2213-2600(12)70044-9
  5. Kirkpatrick d P, Dransfield MT. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 2009;15:100-104. https://doi.org/10.1097/MCP.0b013e3283232825
  6. Dransfield MT, Bailey WC. COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med 2006;27:463-471. https://doi.org/10.1016/j.ccm.2006.04.005
  7. Barnes PJ. Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease. Thorax 1999;54:245-252. https://doi.org/10.1136/thx.54.3.245
  8. Hegab AE, Sakamoto T, Uchida Y, et al. CLCA1 gene polymorphisms in chronic obstructive pulmonary disease. J Med Genet 2004;41:e27. https://doi.org/10.1136/jmg.2003.012484
  9. Ho LI, Harn HJ, Chen CJ, Tsai NM. Polymorphism of the beta(2)-adrenoceptor in COPD in Chinese subjects. Chest 2001;120:1493-1499. https://doi.org/10.1378/chest.120.5.1493
  10. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008;178:332-338. https://doi.org/10.1164/rccm.200712-1869OC
  11. Hansel NN, Washko GR, Foreman MG, et al. Racial differences in CT phenotypes in COPD. COPD 2013;10:20-27. https://doi.org/10.3109/15412555.2012.727921
  12. Kwon N, Amin M, Hui DS, et al. Validity of the COPD assessment test translated into local languages for Asian patients. Chest 2013;143:703-710. https://doi.org/10.1378/chest.12-0535
  13. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Belmont: Wadsworth International Group, 1984.
  14. Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med 1996;335:1198-1205. https://doi.org/10.1056/NEJM199610173351606
  15. Small M, Broomfield S, Higgins V. Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategy. Thorax 2012;67:A144-A145.
  16. Adamek L, Jones P, Nadeau G, Banik N. GOLD 2011: combined COPD assessment of patients from the European health-related quality of life study. Eur Respir J 2012;40(Suppl 56):1644.
  17. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012. https://doi.org/10.1056/NEJMoa021322
  18. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009;374:704-711. https://doi.org/10.1016/S0140-6736(09)61301-5
  19. Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT) scores. BMC Pulm Med 2011;11:42. https://doi.org/10.1186/1471-2466-11-42
  20. Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med 2003;26:172-181. https://doi.org/10.1207/S15324796ABM2603_02
  21. Decramer M, Miravitlles M, Price D, et al. New horizons in early stage COPD: improving knowledge, detection and treatment. Respir Med 2011;105:1576-1587. https://doi.org/10.1016/j.rmed.2010.12.015
  22. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994;272:1497-1505. https://doi.org/10.1001/jama.1994.03520190043033
  23. Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009;374:1171-1178. https://doi.org/10.1016/S0140-6736(09)61298-8

Cited by

  1. COPD assessment test score and serum C-reactive protein levels in stable COPD patients vol.11, pp.None, 2015, https://doi.org/10.2147/copd.s118153
  2. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation vol.13, pp.None, 2015, https://doi.org/10.2147/copd.s149805
  3. The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients vol.18, pp.None, 2015, https://doi.org/10.1186/s12890-018-0601-0
  4. Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease : A systematic review protocol vol.98, pp.37, 2015, https://doi.org/10.1097/md.0000000000017112